Clinical Trial Update: Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of megestrol acetate with or without mirtazapine for cancer patients with weight loss or loss of appetite has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia
• Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• mirtazapine (mirtazapine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Anorexia | Phase 2 | Status: WITHDRAWN